Home Companies Merck & Co

Merck & Co

    Latest
    Coronavirus

    “Game Changer:” After Vaccines, Pfizer Stakes Claim in COVID-19 Drugs, Too

    Merck & Co

    Merck to Seek FDA EUA for COVID-19 Pill after Positive Phase...

    Merck & Co

    Merck & Co. to Acquire Acceleron for $11.5B

    Merck & Co

    ‘Manufacturing-First Approach’ Pays Off for Cell Therapy Developer Artiva

    Merck & Co

    Merck Halves COVID-19 Pipeline; Halts Two Vaccines, Continues Two Drugs

    cancer cell
    Merck & Co

    Merck & Co. to Acquire VelosBio for $2.75B, Expanding Cancer Pipeline

    Merck & Co

    Merck & Co. Commits Up to $4.2B toward Seattle Genetics Cancer...

    Merck & Co

    As Pressure Mounts, CEOs Commit to Science, Safety in Developing COVID-19...

    Merck & Co

    COVID-19 Triple Play: Merck Acquiring Themis, Partnering with Ridgeback, IAVI

    covid-19
    Merck & Co

    Merck & Co. Partnering with ISB to Study Targets for COVID-19...

    1234Page 1 of 4
    Copyright © 2022 Genetic Engineering & Biotechnology News. All Rights Reserved.